A novel three-dimensional heterotypic spheroid model for the assessment of the activity of cancer immunotherapy agents

This study demonstrates that the 3D heterotypic spheroid model provides a novel and versatile tool for in vitro evaluation of cancer immunotherapy agents and allows for assessment of additional aspects of the activity of cancer immunotherapy agents, including a nalysis of immune cell infiltration and drug targeting.
Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research